Bandingkan Harga & Kinerja Jobubu Jarum Minahasa Tbk (BEER) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Jobubu Jarum Minahasa Tbk dan Tempo Scan Pacific Tbk.: Jobubu Jarum Minahasa Tbk diperdagangkan di Rp81 (kapitalisasi pasar 324 M, volume 24 jam 5,1 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.500 (kapitalisasi pasar 11,36 T, volume 24 jam 200 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 35,1× kapitalisasi pasar Jobubu Jarum Minahasa Tbk, dan Jobubu Jarum Minahasa Tbk lebih aktif diperdagangkan (5,1 jt vs 200 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BEER | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 324 M | 11,36 T |
Volume | 5,1 jt | 200 rb |
Lot | 50,98 rb | 2 rb |
Perputaran | 402,52 jt | 500,06 jt |
Harga Rata-rata | 78,96 | 2.500,28 |
Nilai Transaksi | 402,52 jt | 500,06 jt |
Harga Ekuilibrium Indikatif | 81 | 2.500 |
Volume Ekuilibrium Indikatif | 250 | 100 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Jobubu Jarum Minahasa Tbk
PT Jobubu Jarum Minahasa Tbk (the “Company”) was established based on Notarial Deed No. 19 of Theomaris Eddy Boham, S.H., M.H., dated July 25, 2018. The Company started its commercial operations since December 2018. The majority shareholder of the Company is PT Maju Minuman Minahasa and the Company's Ultimate Beneficiary Owner (UBO) is Nico Lieke.
Selengkapnya di halaman BEER →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
